GSK has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding (end-of-period, EOP). GlaxoSmithKline PLC's share price for the quarter that ended in Jun. 2016 was $43.34. GlaxoSmithKline PLC's shares outstanding (EOP) for the quarter that ended in Jun. 2016 was 2,436 Mil. Therefore, GlaxoSmithKline PLC's market cap for the quarter that ended in Jun. 2016 was $105,585 Mil.
GlaxoSmithKline PLC's quarterly market cap increased from Dec. 2015 ($98,248 Mil) to Mar. 2016 ($98,749 Mil) and increased from Mar. 2016 ($98,749 Mil) to Jun. 2016 ($105,585 Mil).
GlaxoSmithKline PLC's annual market cap increased from Dec. 2012 ($106,559 Mil) to Dec. 2013 ($129,748 Mil) but then declined from Dec. 2013 ($129,748 Mil) to Dec. 2014 ($114,443 Mil).
Enterprise value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. GlaxoSmithKline PLC's enterprise value for Today is $127,289 Mil.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
GlaxoSmithKline PLC's Market Cap for the fiscal year that ended in Dec. 2014 is calculated as
|Market Cap (A: Dec. 2014 )||=||Share Price (A: Dec. 2014 )||*||Shares Outstanding (EOP) (A: Dec. 2014 )|
GlaxoSmithKline PLC's Market Cap for the quarter that ended in Jun. 2016 is calculated as
|Market Cap (Q: Jun. 2016 )||=||Share Price (Q: Jun. 2016 )||*||Shares Outstanding (EOP) (Q: Jun. 2016 )|
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
GlaxoSmithKline PLC Annual Data
GlaxoSmithKline PLC Quarterly Data
Disclaimers: GuruFocus.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The gurus may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.